Related Articles
Phase I clinical trial of peptide vaccination with URLC10 and VEGFR1 epitope peptides in patients with advanced gastric cancer
miR-196b, miR-378a and miR-486 are predictive biomarkers for the efficacy of vaccine treatment in colorectal cancer
Dendritic cell-based vaccination in metastatic melanoma patients: Phase II clinical trial
Personalized peptide vaccination for advanced biliary tract cancer: IL-6, nutritional status and pre-existing antigen-specific immunity as possible biomarkers for patient prognosis
Phase I clinical trial of a novel peptide vaccine in combination with UFT/LV for metastatic colorectal cancer